140 related articles for article (PubMed ID: 33080304)
1. iRHOM2: A Regulator of Palmoplantar Biology, Inflammation, and Viral Susceptibility.
Chao-Chu J; Murtough S; Zaman N; Pennington DJ; Blaydon DC; Kelsell DP
J Invest Dermatol; 2021 Apr; 141(4):722-726. PubMed ID: 33080304
[TBL] [Abstract][Full Text] [Related]
2. iRHOM2-dependent regulation of ADAM17 in cutaneous disease and epidermal barrier function.
Brooke MA; Etheridge SL; Kaplan N; Simpson C; O'Toole EA; Ishida-Yamamoto A; Marches O; Getsios S; Kelsell DP
Hum Mol Genet; 2014 Aug; 23(15):4064-76. PubMed ID: 24643277
[TBL] [Abstract][Full Text] [Related]
3. Rhomboid family member 2 regulates cytoskeletal stress-associated Keratin 16.
Maruthappu T; Chikh A; Fell B; Delaney PJ; Brooke MA; Levet C; Moncada-Pazos A; Ishida-Yamamoto A; Blaydon D; Waseem A; Leigh IM; Freeman M; Kelsell DP
Nat Commun; 2017 Jan; 8():14174. PubMed ID: 28128203
[TBL] [Abstract][Full Text] [Related]
4. Pathological mutations reveal the key role of the cytosolic iRhom2 N-terminus for phosphorylation-independent 14-3-3 interaction and ADAM17 binding, stability, and activity.
Bläsius K; Ludwig L; Knapp S; Flaßhove C; Sonnabend F; Keller D; Tacken N; Gao X; Kahveci-Türköz S; Grannemann C; Babendreyer A; Adrain C; Huth S; Baron JM; Ludwig A; Düsterhöft S
Cell Mol Life Sci; 2024 Feb; 81(1):102. PubMed ID: 38409522
[TBL] [Abstract][Full Text] [Related]
5. Analysis of the function of ADAM17 in iRhom2 curly-bare and tylosis with esophageal cancer mutant mice.
Rabinowitsch AI; Maretzky T; Weskamp G; Haxaire C; Tueshaus J; Lichtenthaler SF; Monette S; Blobel CP
J Cell Sci; 2023 Jul; 136(13):. PubMed ID: 37282854
[TBL] [Abstract][Full Text] [Related]
6. Deletions in the cytoplasmic domain of iRhom1 and iRhom2 promote shedding of the TNF receptor by the protease ADAM17.
Maney SK; McIlwain DR; Polz R; Pandyra AA; Sundaram B; Wolff D; Ohishi K; Maretzky T; Brooke MA; Evers A; Vasudevan AA; Aghaeepour N; Scheller J; Münk C; Häussinger D; Mak TW; Nolan GP; Kelsell DP; Blobel CP; Lang KS; Lang PA
Sci Signal; 2015 Nov; 8(401):ra109. PubMed ID: 26535007
[TBL] [Abstract][Full Text] [Related]
7. p63 is a key regulator of iRHOM2 signalling in the keratinocyte stress response.
Arcidiacono P; Webb CM; Brooke MA; Zhou H; Delaney PJ; Ng KE; Blaydon DC; Tinker A; Kelsell DP; Chikh A
Nat Commun; 2018 Mar; 9(1):1021. PubMed ID: 29523849
[TBL] [Abstract][Full Text] [Related]
8. Whole Exome Sequencing Identified a Novel Mutation of the RHBDF2 Gene in a Chinese Family of Tylosis with Esophageal Cancer.
Qu L; Sha S; Zou QL; Gao XH; Xiao T; Chen HD; He CC
Acta Derm Venereol; 2019 Jun; 99(7):699-700. PubMed ID: 30938830
[No Abstract] [Full Text] [Related]
9. iRhom2: An Emerging Adaptor Regulating Immunity and Disease.
Al-Salihi MA; Lang PA
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32911849
[TBL] [Abstract][Full Text] [Related]
10. ADAM17 stabilizes its interacting partner inactive Rhomboid 2 (iRhom2) but not inactive Rhomboid 1 (iRhom1).
Weskamp G; Tüshaus J; Li D; Feederle R; Maretzky T; Swendemann S; Falck-Pedersen E; McIlwain DR; Mak TW; Salmon JE; Lichtenthaler SF; Blobel CP
J Biol Chem; 2020 Mar; 295(13):4350-4358. PubMed ID: 32060096
[TBL] [Abstract][Full Text] [Related]
11. iRhom2 regulates CSF1R cell surface expression and non-steady state myelopoiesis in mice.
Qing X; Rogers L; Mortha A; Lavin Y; Redecha P; Issuree PD; Maretzky T; Merad M; McIlwain D; Mak TW; Overall CM; Blobel CP; Salmon JE
Eur J Immunol; 2016 Dec; 46(12):2737-2748. PubMed ID: 27601030
[TBL] [Abstract][Full Text] [Related]
12. Tylosis associated with squamous cell carcinoma of the oesophagus (TOC): Report of an African family with a novel RHBDF2 variant.
Mokoena T; Smit JGM; Karusseit VO; Dorfling CM; van Rensburg EJ
Clin Genet; 2018 May; 93(5):1114-1116. PubMed ID: 29372562
[No Abstract] [Full Text] [Related]
13. iRhom2 regulates ERBB signalling to promote KRAS-driven tumour growth of lung cancer cells.
Sieber B; Lu F; Stribbling SM; Grieve AG; Ryan AJ; Freeman M
J Cell Sci; 2022 Sep; 135(17):. PubMed ID: 35971826
[TBL] [Abstract][Full Text] [Related]
14. iRhom2 inhibits bile duct obstruction-induced liver fibrosis.
Sundaram B; Behnke K; Belancic A; Al-Salihi MA; Thabet Y; Polz R; Pellegrino R; Zhuang Y; Shinde PV; Xu HC; Vasilevska J; Longerich T; Herebian D; Mayatepek E; Bock HH; May P; Kordes C; Aghaeepour N; Mak TW; Keitel V; Häussinger D; Scheller J; Pandyra AA; Lang KS; Lang PA
Sci Signal; 2019 Oct; 12(605):. PubMed ID: 31662486
[TBL] [Abstract][Full Text] [Related]
15. Mechanistic insight on the role of iRhom2-TNF-α-BAFF signaling pathway in various autoimmune disorders.
Dwivedi SD; Shukla R; Yadav K; Rathor LS; Singh D; Singh MR
Adv Biol Regul; 2024 May; 92():101011. PubMed ID: 38151421
[TBL] [Abstract][Full Text] [Related]
16. Cryo-EM reveals that iRhom2 restrains ADAM17 protease activity to control the release of growth factor and inflammatory signals.
Lu F; Zhao H; Dai Y; Wang Y; Lee CH; Freeman M
Mol Cell; 2024 Jun; 84(11):2152-2165.e5. PubMed ID: 38781971
[TBL] [Abstract][Full Text] [Related]
17. RHBDF2 mutations are associated with tylosis, a familial esophageal cancer syndrome.
Blaydon DC; Etheridge SL; Risk JM; Hennies HC; Gay LJ; Carroll R; Plagnol V; McRonald FE; Stevens HP; Spurr NK; Bishop DT; Ellis A; Jankowski J; Field JK; Leigh IM; South AP; Kelsell DP
Am J Hum Genet; 2012 Feb; 90(2):340-6. PubMed ID: 22265016
[TBL] [Abstract][Full Text] [Related]
18. Cleavage of the pseudoprotease iRhom2 by the signal peptidase complex reveals an ER-to-nucleus signaling pathway.
Dulloo I; Tellier M; Levet C; Chikh A; Zhang B; Blaydon DC; Webb CM; Kelsell DP; Freeman M
Mol Cell; 2024 Jan; 84(2):277-292.e9. PubMed ID: 38183983
[TBL] [Abstract][Full Text] [Related]
19. Altered keratinocyte differentiation is an early driver of keratin mutation-based palmoplantar keratoderma.
Zieman AG; Poll BG; Ma J; Coulombe PA
Hum Mol Genet; 2019 Jul; 28(13):2255-2270. PubMed ID: 31220272
[TBL] [Abstract][Full Text] [Related]
20. Status update on iRhom and ADAM17: It's still complicated.
Düsterhöft S; Babendreyer A; Giese AA; Flasshove C; Ludwig A
Biochim Biophys Acta Mol Cell Res; 2019 Oct; 1866(10):1567-1583. PubMed ID: 31330158
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]